UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 
 

Date of Report (Date of the earliest event reported)

August 31, 2015

 
 
 
ULTRALIFE CORPORATION
(Exact name of registrant as specified in its charter)
 
 
 
Delaware 000-20852 16-1387013
(State of incorporation) (Commission File Number) (IRS Employer Identification No.)
 
2000 Technology Parkway, Newark, New York 14513
(Address of principal executive offices) (Zip Code)
 
(315) 332-7100
(Registrant’s telephone number, including area code)
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
       
 
 

Item 8.01 Other Events

In a press release dated September 1, 2015, Ultralife Corporation (NASDAQ: ULBI) announced that its Communications Systems business has been awarded a contract valued at approximately $8.2 million to supply its Soldier Radio Waveform (“SRW”) Vehicle Installed Power Enhanced Rifleman Appliqué (“VIPER”) systems to Thales Defense & Security, Inc., a global leader in the development, manufacture, and support of combat-proven, software-defined radio (SDR) equipment, for the U.S. Army.

 

 

 

 Item 9.01 Financial Statements, Pro Forma Financials and Exhibits

(d)        Exhibits 

              99.1 Press Release of Ultralife Corporation dated September 1, 2015.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ULTRALIFE CORPORATION
   
September 1, 2015 By: /s/ Philip A. Fain
    Chief Financial Officer and Treasurer